FDA issued a Warning Letter to AllerQuest LLC on 6/24/2019 as a result of this inspection.

483 AllerQuest Mar 2019

FDA investigators audited the AllerQuest - Plainville, CT, United States facility and issued inspectional observations (via FDA 483) on 01 Mar 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 01 Mar 2019
  • Location: Plainville, United States
  • FEI: 3006900385
No 483 recorded for this inspection.